Company: NCNO
Filing Date: 2025-08-26
Form Type: 10-Q
Source: 0001902733-25-000106
Chunk: 59

Company: nCino, Inc.
Filing Date: 2025-08-26
Form: 10-Q
Item: Part I, Item 1
Chunk 59
---
)Other accounts receivable1,960 1,263 Total accounts receivable, net$146,787 $98,468 Deferred Revenue and Remaining Performance ObligationsSignificant movements in the deferred revenue balance during the period consisted of increases due to payments received or due in advance prior to the transfer of control of the underlying performance obligations to the customer, which were offset by decreases due to revenues recognized in the period. During the six months ended July 31, 2025, $154.6 million of revenues were recognized out of the deferred revenue balance as of January 31, 2025.Remaining performance obligations were $1.2 billion as of July 31, 2025. The Company expects to recognize approximately 69% of its remaining performance obligation as revenues in the next 24 months, approximately 26% more in the following 25 to 48 months, and the remainder thereafter.

13

Table of ContentsnCino, Inc.NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(In thousands, except share and per share amounts and unless otherwise indicated)

Note 5. Balance Sheet Components

Prepaid expenses and other current assetsPrepaid expenses and other current assets consisted of the following:As of January 31,2025As of July 31,2025Prepaid expenses$19,729 $17,465 Other current assets1,343 1,918 Prepaid expenses and other current assets$21,072 $19,383 Property and equipment, netProperty and equipment, net consisted of the following:As of January 31, 2025As of July 31, 2025Furniture and fixtures$11,712 $10,992 Computers and equipment7,193 7,171 Buildings and land56,379 56,379 Leasehold improvements28,046 24,358 Construction in progress627 6,685 103,957 105,585 Less accumulated depreciation(29,004)(28,155)$74,953 $77,430 The Company recognized depreciation expense as follows:Three Months Ended July 31,Six Months Ended July 31,2024202520242025Cost of subscription revenues$121 $118 $242 $226 Cost of professional services and other revenues327 339 669 684 Sales and marketing323 306 665 616 Research and development619 518